Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide for abdominal girth in irritable bowel syndrome with constipation
2016-000818-29Phase 4Terminated
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Jun 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Linaclotide with Placebo (2 arms). Primary endpoint: Mean change in abdominal girth. Started Jun 2016; status: terminated.
02
Drugs
linaclotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2016-000818-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000818-29.